Concepedia

Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial

Amanda E. Coleman, Scott A. Brown, Anne M. Traas, Lawrence Bryson, Tanja Zimmering, Alicia Zimmerman

Journal of Veterinary Internal Medicine · 2019 · 38 citations · 39 references

DOIFull text

Open access

Abstract

Telmisartan significantly decreased SBP to a clinically relevant extent and was well tolerated in hypertensive cats.

References

39

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

Paul A. James, Suzanne Oparil, Barry L. Carter et al. · JAMA · 2013 · 7.9K citations

, , +20

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 5.9K citations · Full text

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

The Lancet · 1997 · 1.8K citations

, , +9

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

Giuseppe Maschio, Daniele Alberti, G. Janin et al. · New England Journal of Medicine · 1996 · 1.8K citations

Guidelines for the Identification, Evaluation, and Management of Systemic Hypertension in Dogs and Cats

Scott A. Brown, Clarke E. Atkins, R. Bagley et al. · Journal of Veterinary Internal Medicine · 2007 · 640 citations · Full text